the acquisition means nothing..., page-2

Hi Wegian,

Just in case you didn't see in the announcement. Mark mentioned profitability a couple times. It would seem that the new entity would be profitable - combined with future savings from synergies etc.
I think this is huge for MLA (so long as existing Shareholders aren't disadvantaged) and will hopefully get MLA back on the radar improving interest and share-turnover.

from the announcement:

"MLA Managing Director, Mark Donnison, said: “This is a company transforming acquisition for MLA, as it creates a unique and profitable human and animal healthcare company with unparalleled capabilities and competitive market advantages. Once the transaction is completed, MLA will have a truly global presence and the financial flexibility to fast-track growth in both the human and animal healthcare markets."

“By combining MediVet’s expertise in the animal health market and MLA’s brand heritage and supply chain processes, we now have the opportunity to achieve significant cost and scale efficiencies and improved profitability. These synergies deliver further upside potential and position the new business on a path of rapid growth across multiple markets.”